| (7) |
| (a) | "Unprofessional conduct" includes, for an individual licensed under this chapter:
| (i) | the conduct that constitutes unprofessional conduct under Section 58-1-501; |
| (ii) | communicating to a third party, without the consent of the patient, information the individual acquires in treating the patient, except as necessary for professional consultation regarding treatment of the patient; |
| (iii) | allowing the individual's name or license to be used by an individual who is not licensed to practice podiatry under this chapter; |
| (iv) | except as described in Section 58-5a-306, employing, directly or indirectly, any unlicensed individual to practice podiatry; |
| (v) | using alcohol or drugs, to the extent the individual's use of alcohol or drugs impairs the individual's ability to practice podiatry; |
| (vi) | unlawfully prescribing, selling, or giving away any prescription drug, including controlled substances, as defined in Section 58-37-101; |
| (vii) | gross incompetency in the practice of podiatry; |
| (viii) | willfully and intentionally making a false statement or entry in hospital records, medical records, or reports; |
| (ix) | willfully making a false statement in reports or claim forms to governmental agencies or insurance companies with the intent to secure payment not rightfully due; |
| (x) | willfully using false or fraudulent advertising; |
| (xi) | conduct the division defines as unprofessional conduct by rule made in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act; |
| (xii) | falsely making an entry in, or altering, a medical record with the intent to conceal:
| (A) | a wrongful or negligent act or omission of an individual licensed under this chapter or an individual under the direction or control of an individual licensed under this chapter; or |
|
| (xiii) | violating the requirements of Title 26B, Chapter 4, Part 2, Cannabinoid Research and Medical Cannabis. |
|
| (b) | "Unprofessional conduct" does not include, in accordance with Title 26B, Chapter 4, Part 2, Cannabinoid Research and Medical Cannabis, when acting as a recommending medical provider, as that term is defined in Section 26B-4-201, recommending the use of medical cannabis within the scope of practice of podiatry. |
|